S-1226: Clinical Trials

3 trials of S-1226, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 suspended. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 2, Suspended 1

Follow S-1226: new trials by email Literature Review of S-1226 trials Research Report on S-1226

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia
S-1226 - Covid19, SARS-CoV-2 Infection
Phase 2SuspendedSolAeroMed Inc.302021-09-152021-08-23
Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.
S-1226 (8%), Placebo - Post Acute COVID-19 Syndrome, Long COVID
Phase 2UnknownSolAeroMed Inc.482021-09-012021-08-23
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
S-1226 - Cystic Fibrosis, Bronchiectasis
Phase 2UnknownSolAeroMed Inc.122019-08-082021-06-16

Conditions studied

Asthma (1)  ·  Bronchiectasis (1)  ·  COVID-19 (1)  ·  Cystic Fibrosis (1)  ·  Post-Acute COVID-19 Syndrome (1)

Sponsors

SolAeroMed Inc. (3)

Countries

Canada (2)

Top investigators

Mark Montgomery, MD (3)